EFFECT OF ZEIN ON CIPROFLOXACIN FLOATING TABLETS
DOI:
https://doi.org/10.22159/ijap.2022v14i6.45354Keywords:
Ciprofloxacin hydrochloride, Zein, Peptic ulcer, Gastroretentive drug delivery, Higuchi model, Floating timeAbstract
Objective: This work was aimed to formulate and evaluate the effect of zein on Ciprofloxacin HCl floating tablets. According to previous studies, it was set up to be useful against bacteria i.e. Helicobacter pylori which leads to peptic ulcers. Thus, it is quite necessary to enhance the Gastric Retention Time for similar medicines.
Methods: 12 different floating tablets of Ciprofloxacin HCl were formulated with wet granulation method with a rise in the concentration of zein. Further, all different formulations prepared were evaluated for different parameters i.e. pre-compression considerations, along with post-compression factors like weight variation, content uniformity, thickness, visual assessment, hardness, friability, buoyancy studies i.e. total floating time as well as floating lag time, swelling index, dissolution and drug release kinetics.
Results: The F6 formulation was considered to be among finest formulation with appropriate hardness. It was found that with the increasing concentration of zein, the hardness of tablets was also increased. It showed TFT of more than 7 h, FLT of 310 sec, a swelling index time of 99.5 % in 4 hr, while drug release kinetics was found to follow Higuchi Model.
Conclusion: Overall it was also found that HPMCK-100M is more effective as compared to HPMC-K15M and Zein has a major role in increasing the hardness of tablets. In the future, the investigation will be continued with the following studies: An in vivo study and a long-term stability study.
Downloads
References
Kumar A, Srivastava R. In vitro in vivo studies on floating microspheres for gastroretentive drug delivery system: a review. Asian J Pharm Clin Res. 2021 Jan 5:13-26.
Rajora A, Nagpal K. A critical review on floating tablets as a tool for achieving better gastric retention. Crit Rev Ther Drug Carrier Syst. 2022;39(1):65-103. doi: 10.1615/CritRev TherDrugCarrierSyst.2021038568, PMID 34936318.
Thulluru A, Basha SS, Rao CB, Kumar CSP, Mahammed N, Kumar KS. Optimization of HPMC K100M and sodium alginate ratio in metronidazole Floating Tablets for the Effective Eradication of Helicobacter pylori. Asian J Pharm Technol. 2019;9(3):195-203. doi: 10.5958/2231-5713.2019.00033.3.
Siahaan RD, Bangun H, Sumaiyah S. In vitro and in vivo evaluation of floating gastroretentive drug delivery system of cimetidine using hard alginate capsules. Asian J Pharm Clin Res. 2018 Jun 7:162-8.
Roy A, Arees R, Blr M. Formulation development of oral fast-dissolving films of Rupatadine fumarate. Asian J Pharm Clin Res. 2020;13(11):67-72.
Jhain SK, Jhain NK, Agarwal GP. Gastro retentive floating drug delivery: an overview. Drug Deliv Technol. 2005;5:21-31.
Banker GS, Anderson NR. Tablets. In: Lachman L, Lieberman A, Kanig JL, editors. The theory and practice of industrial pharmacy. 3rd ed. Bombay: Varghese publishing house; 1991. p. 317.
Vyas J, Mehta J, Pal N, Daxini K. Development and optimization of floating tablets containing rebamipide. Rese Jour Pharmaceut Dosag Form and Technol. 2020;12(1):7-12. doi: 10.5958/0975-4377.2020.00002.6.
Carr RL. Evaluation of flow properties of solid. Chem Eng. 1965;3:163-8.
Manoj G, Rajesh P, Kapil KP, Mehta SC. Floating drug delivery system. J Curr Pharm Res. 2011;5:7-18.
Dodou D, Breedveld P, Wieringa PA. Mucoadhesives in the gastrointestinal tract: revisiting the literature for novel applications. Eur J Pharm Biopharm. 2005;60(1):1-16. doi: 10.1016/j.ejpb.2005.01.007, PMID 15848050.
Brahmankar DM, Jaiswal SB. Biopharmaceutics and pharmacokinetics a treatise. Vallabh Prakashan New Delhi; 1995. p. 64-70.
Mayavanshi AV, Gajjar SS. Floating drug delivery systems to increase gastric retention of drugs: a review. Res J Pharm Technol. 2008;1:345-8.
Tadros MI. Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro-in vivo evaluation in healthy human volunteers. Eur J Pharm Biopharm. 2010;74(2):332-9. doi: 10.1016/j.ejpb.2009.11.010, PMID 19932750.
Pharmacopoeia I. Government of India Ministry of Health and Family Welfare, Published by the Indian Pharmacopoeia Commission. Volume 1st. 2007;477(478):177-83.
Debjit Bhowmik CB, Krishnakanth P, Chandira RM. Fast dissolving tablet an overview. J Chem Pharm Res. 2009;1:163-77.
Amrutha JV. Pre and post-compression studies of tablets. Inorg Chem Indian J. 2016;3:1-10.
Reddy VS. Formulation and evaluation of floating tablets of ciprofloxacin hydrochloride. Asian J Pharm Free Full Text Artic Asian J Pharm. 2018;12.
Pharmaceutical technology Editors, Achieving Zero-Order Release Kinetics Using Multi-Step Diffusion-Based Drug Delivery. Pharm Technol. 2014;5.
Patel H, Panchal DR, Patel U, Brahmbhatt T. Matrix type drug delivery system: a review. J Pharm Sci Biosci Res. 2011;1:143-51.
Gaikwad VD, Yadav VD, Gaikwad MD. Novel sustained release and swellable gastroretentive dosage form for ciprofloxacin hydrochloride. Int J Pharm Investig. 2014;4(2):88-92. doi: 10.4103/2230-973X.133057, PMID 25006553.
Deshpande AA, Rhodes CT, Shah NH, Malick AW. Controlled-release drug delivery systems for prolonged gastric residence: an overview. Drug Dev Ind Pharm. 1996;22(6):531-9. doi: 10.3109/03639049609108355.
Arza RA, Gonugunta CS, Veerareddy PR. Formulation and evaluation of swellable and floating gastroretentive ciprofloxacin hydrochloride tablets. AAPS PharmSciTech. 2009;10(1):220-6. doi: 10.1208/s12249-009-9200-y, PMID 19277869.
Prajapati ST, Patel LD, Patel DM. Gastric floating matrix tablets: design and optimization using a combination of polymers. Acta Pharm. 2008;58(2):221-9. doi: 10.2478/v10007-008-0006-3, PMID 18515232.
Sauzet C, Claeys Bruno M, Nicolas M, Kister J, Piccerelle P, Prinderre P. An innovative floating gastro retentive dosage system: formulation and in vitro evaluation. Int J Pharm. 2009;378(1-2):23-9. doi: 10.1016/j.ijpharm.2009.05.027, PMID 19465095.
Garg R, Gupta GD. Progress in controlled gastroretentive delivery systems. Trop J Pharm Res. 2008;7(3):1055-66. doi: 10.4314/tjpr.v7i3.14691.
Xu X, Sun M, Zhi F, Hu Y. Floating matrix dosage form for phenoporlamine hydrochloride based on gas forming agent: in vitro and in vivo evaluation in healthy volunteers. Int J Pharm. 2006;310(1-2):139-45. doi: 10.1016/j.ijpharm.2005.12.003, PMID 16413710.
Deshpande AA, Shah NH, Rhodes CT, Malick W. Development of a novel controlled-release system for gastric retention. Pharm Res. 1997;14(6):815-9. doi: 10.1023/a:1012171010492, PMID 9210203.
Chavanpatil MD, Jain P, Chaudhari S, Shear R, Vavia PR. R. Novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacin. Int J Pharm. 2006;316(1-2):86-92. doi: 10.1016/j.ijpharm.2006.02.038, PMID 16567072.
Hwang SJ, Park H, Park K. Gastric retentive drug-delivery systems. Crit Rev Ther Drug Carrier Syst. 1998;15(3):243-84. PMID 9699081.
Patel N, Nagesh C, Chandrashekhar S, Jinal P, Devdatt J. Floating drug delivery system: an acceptable innovative approach in gastroretentive drug delivery. Res Pharm Forms Technol. 2012;4(2):93-103.
Sheth PR, Tossounian J. The hydrodynamically balanced system (Hbs™): A novel drug delivery system for oral use. Drug Dev Ind Pharm. 1984;10(2):313-39. doi: 10.3109/ 03639048409064653.
Hondadakatti R, Iliger SR, Lagali M. Formulation and evaluation of floating drug delivery system of antidiabetic drug. RJPDFT. 2021 Apr 1;13(2):100-6. doi: 10.52711/0975-4377.2021.00018.
Harrigan RM. Drug delivery device for preventing contact of the undissolved drug with the stomach lining. US Patent 4055178; 1977 Oct 25.
Whitehead L, Fell JT, Collett JH. Development of a gastroretentive dosage form. Eur J Pharm Sci. 1996;4:S182.
Kawashima Y, Niwa T, Takeuchi H, Hino T, Itoh Y. Hollow microspheres for use as a floating controlled drug delivery system in the stomach. J Pharm Sci. 1992;81(2):135-40. doi: 10.1002/jps.2600810207, PMID 1372046.
Chen J, Blevins WE, Park H, Park K. Gastric retention properties of super porous hydrogel composites. J Control Release. 2000;64(1-3):39-51. doi: 10.1016/s0168-3659(99)00139-x, PMID 10640644.
Groning R, Berntgen M, Georgarakis M. Acyclovir serum concentrations following peroral administration of magnetic depot tablets and the influence of extracorporal magnets to control gastrointestinal transit. Eur J Pharm Biopharm. 1998;46(3):285-91. doi: 10.1016/s0939-6411(98)00052-6, PMID 9885300.
Singh BN, Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release. 2000;63(3):235-59. doi: 10.1016/s0168-3659(99)00204-7, PMID 10601721.
Philadelphia: Lippincott Williams & Wilkins. Remington: the science and practice of pharmacy. 21st ed; 2005.
Jeong YI, Na HS, Seo DH, Kim DG, Lee HC, Jang MK. Ciprofloxacin-encapsulated poly (DL-lactide-co-glycolide) nanoparticles and its antibacterial activity. Int J Pharm. 2008;352(1-2):317-23. doi: 10.1016/j.ijpharm.2007.11.001, PMID 18160236.
Jeong YI, Na HS, Nah JW, Lee HC. Preparation of ciprofloxacin-encapsulated poly (DL-lactide-co-glycolide) microspheres and its antibacterial activity. J Pharm Sci. 2009;98(10):3659-65. doi: 10.1002/jps.21680, PMID 19226632.
Hajare AA, Patil VA. Formulation and characterization of metformin hydrochloride floating tablets. Asian J Pharm Res. 2012;2(3):111-7.
Arza RA, Gonugunta CS, Veerareddy PR. Formulation and evaluation of swellable and floating gastroretentive ciprofloxacin hydrochloride tablets. AAPS PharmSciTech. 2009;10(1):220-6. doi: 10.1208/s12249-009-9200-y, PMID 19277869.
Salve PS. Development and in vitro evaluation of gas generating floating tablets of metformin hydrochloride. Asian J Res Pharm Sci. 2011;1(4):105-12.
Varshosaz J, Tavakoli N, Roozbahani F. Formulation and in vitro characterization of ciprofloxacin floating and bioadhesive extended-release tablets. Drug Deliv. 2006;13(4):277-85. doi: 10.1080/10717540500395106, PMID 16766469.
Srinatha A, Pandit JK. Multi-unit floating alginate system: effect of additives on ciprofloxacin release. Drug Deliv. 2008;15(7):471-6. doi: 10.1080/10717540802329282, PMID 18712625.
Raza A, Hayat U, Wang HJ, Wang JY. Preparation and evaluation of captopril-loaded gastro-retentive zein-based porous floating tablets. Int J Pharm. 2020;15579;(579):119185. doi: 10.1016/j.ijpharm.2020.119185, PMID 32112929.
Georget DM, Barker SA, Belton PS. A study on maize proteins as a potential new tablet excipient. Eur J Pharm Biopharm. 2008 Jun;69(2):718-26. doi: 10.1016/j.ejpb.2008.01.006, PMID 18294824.
Wang GW, Yang H, Wu WF, Zhang P, Wang JY. Design and optimization of a biodegradable porous zein conduit using microtubes as a guide for rat sciatic nerve defect repair. Biomaterials. 2017 Jul;131:145-59. doi: 10.1016/j.biomaterials.2017.03.038, PMID 28391036.
Kim S, Hwang KM, Park YS, Nguyen TT, Park ES. Preparation and evaluation of non-effervescent gastroretentive tablets containing pregabalin for once-daily administration and dose proportional pharmacokinetics. Int J Pharm. 2018 Oct 25;550(1-2):160-9. doi: 10.1016/j.ijpharm.2018.08.038, PMID 30138708.
Guo HX, Shi YP. A novel zein-based dry coating tablet design for zero-order release. Int J Pharm. 2009 Mar 31;370(1-2):81-6. doi: 10.1016/j.ijpharm.2008.11.026, PMID 19100825.
Nguyen MNU, Tran PHL, Tran TTD. A single-layer film coating for colon-targeted oral delivery. Int J Pharm. 2019 Mar 25;559:402-9. doi: 10.1016/j.ijpharm.2019.01.066, PMID 30738130.
Wang H, Zhang X, Zhu W, Jiang Y, Zhang Z. Self-assembly of zein-based microcarrier system for colon-targeted oral drug delivery. Ind Eng Chem Res. 2018 Sep 5;57(38):12689-99. doi: 10.1021/acs.iecr.8b02092.
Berardi A, Bisharat L, Cespi M, Basheti IA, Bonacucina G, Pavoni L, AlKhatib HS. Controlled release properties of zein powder filled into hard gelatin capsules. Powder Technol. 2017 Oct 1;320:703-13. doi: 10.1016/j.powtec.2017.07.093.
Raza A, Shen N, Li J, Chen Y, Wang JY. Formulation of zein-based compression coated floating tablets for enhanced gastric retention and tunable drug release. Eur J Pharm Sci. 2019 Apr 30;132:163-73. doi: 10.1016/j.ejps.2019.01.025, PMID 30695689.
Gong S, Wang H, Sun Q, Xue ST, Wang JY. Mechanical properties and in vitro biocompatibility of porous zein scaffolds. Biomaterials. 2006 Jul;27(20):3793-9. doi: 10.1016/j.biomaterials.2006.02.019, PMID 16527348.
Hwang KM, Cho CH, Tung NT, Kim JY, Rhee YS, Park ES. Release kinetics of highly porous floating tablets containing cilostazol. Eur J Pharm Biopharm. 2017 Jun;115:39-51. doi: 10.1016/j.ejpb.2017.01.027, PMID 28219750.
Thapa P, Jeong SH. Effects of formulation and process variables on gastroretentive floating tablets with A high-dose soluble drug and experimental design approach. Pharmaceutics. 2018 Sep 17;10(3):161. doi: 10.3390/pharmaceutics10030161, PMID 30227678.
Published
How to Cite
Issue
Section
Copyright (c) 2022 ANSHIKA SINGH, ANJALI RAJORA, RUPA MAZUMDER, SWARUPANJALI PADHI
This work is licensed under a Creative Commons Attribution 4.0 International License.
